- Home
- LMFA vs AEON Comparison
LMFA vs AEON Comparison
Compare LMFA & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- AEON
- Stock Information
- Founded
- LMFA 2008
- AEON N/A
- Country
- LMFA United States
- AEON United States
- Employees
- LMFA N/A
- AEON 5
- Industry
- LMFA Finance: Consumer Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- AEON Health Care
- Exchange
- LMFA Nasdaq
- AEON Nasdaq
- Market Cap
- LMFA 8.6M
- AEON 8.0M
- IPO Year
- LMFA 2015
- AEON N/A
- Fundamental
- Price
- LMFA $2.86
- AEON $0.74
- Analyst Decision
- LMFA Hold
- AEON Strong Buy
- Analyst Count
- LMFA 1
- AEON 1
- Target Price
- LMFA N/A
- AEON $360.00
- AVG Volume (30 Days)
- LMFA 105.5K
- AEON 435.0K
- Earning Date
- LMFA 08-13-2025
- AEON 08-11-2025
- Dividend Yield
- LMFA N/A
- AEON N/A
- EPS Growth
- LMFA N/A
- AEON N/A
- EPS
- LMFA N/A
- AEON 117.22
- Revenue
- LMFA $8,029,601.00
- AEON N/A
- Revenue This Year
- LMFA $0.98
- AEON N/A
- Revenue Next Year
- LMFA $4.31
- AEON N/A
- P/E Ratio
- LMFA N/A
- AEON $0.01
- Revenue Growth
- LMFA N/A
- AEON N/A
- 52 Week Low
- LMFA $1.02
- AEON $0.38
- 52 Week High
- LMFA $5.35
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- LMFA 76.89
- AEON 50.96
- Support Level
- LMFA $2.18
- AEON $0.68
- Resistance Level
- LMFA $2.46
- AEON $0.81
- Average True Range (ATR)
- LMFA 0.21
- AEON 0.09
- MACD
- LMFA 0.09
- AEON -0.01
- Stochastic Oscillator
- LMFA 97.64
- AEON 18.64
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.